WALTHAM, Mass., May 25, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences taking place in June 2016.
- Jefferies 2016 Healthcare Conference
Presentation: Tuesday, June 7, 2016 at 10:00 a.m. ET*
One-on-one meetings: Tuesday, June 7, 2016
Location: New York, NY - Barclays High Yield Bond & Syndicated Loan Conference
Presentation: Thursday, June 9, 2016 at 5:25 p.m. ET*
One-on-one meetings: Thursday, June 9, 2016
Location: Colorado Springs, CO
*A live webcast of the presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com, and will be archived for 30 days.
About AMAG
AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives. Headquartered in Waltham, MA, AMAG possesses a diverse portfolio of products to support the health of patients in the areas of maternal health, anemia management and cancer supportive care. Through CBR®, the company also helps families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. and CBR® is a registered trademark of CBR Systems, Inc.